A new global risk assessment tool makes its debut, and nontraditional risk factors take a back seat.
Journal Watch点评 ACC/AHA心血管风险评估指南
Kirsten E. Fleischmann, MD, MPH reviewing Goff DC Jr et al.
A new global risk assessment tool makes its debut, and nontraditional risk factors take a back seat.
Sponsoring Organizations: American College of Cardiology, American Heart Association
Target Population: Primary care providers, cardiologists
Background and Objective
The ACC/AHA Task Force based these recommendations on a comprehensive report from an Expert Work Group convened by the National Heart, Lung, and Blood Institute. The Work Group was asked to (1) develop an approach to quantitative risk assessment for cardiovascular disease that could be used to guide care; and (2) address key questions in risk assessment using systematic review methods.
Key Points
New, sex-specific Pooled Cohort Equations were developed from multiple large cohorts to predict the 10-year risk for a first atherosclerotic cardiovascular disease event (ASCVD; nonfatal myocardial infarction, coronary heart disease death, or fatal or nonfatal stroke) and are recommended for non-Hispanic blacks and non-Hispanic whites.
The Pooled Cohort Equations may also be used in other populations, keeping in mind that the validity of the model is not as well established as in non-Hispanic blacks and whites.
Inputs for the new equations include age, sex, cholesterol (total and HDL) and blood-pressure values, and information on other standard risk factors.
If, after risk assessment, the treatment decision is still uncertain, assessment of family history, high-sensitivity C-reactive protein, coronary artery calcium, or ankle-brachial index may be considered.
Routine measurement of carotid intima-media thickness (CIMT) is not recommended for assessment of risk for a first ASCVD event.
The incremental value of apolipoprotein B, chronic kidney disease, albuminuria, and cardiorespiratory fitness in risk assessment for a first ASCVD event is uncertain.
What's Changed
This document supplants guidelines published by the ACC/AHA in 2010 (NEJM JW Cardiol Feb 9 2011). Notable changes from the previous guidelines include the endorsement of a specific model for global risk assessment and a diminution of the role of CIMT measurement.
-------------------------------------------------------------
补充阅读:
2013年11月12日,美国心脏病学会(ACC)和美国心脏协会(AHA),联合美国国家心脏,肺和血液研究所(NHLBI)及其他专业社团,共同发布了四份指南,指南内容涉及心血管疾病的风险评估准则、生活方式的改变,以及控制血液胆固醇减少心血管疾病的风险,并在成人肥胖和体重管理。
四份指南下载地址>>(点击查看指南及相应评论)
1.《 2013 ACC/AHA 控制血液胆固醇降低成人动脉粥样硬化性心血管风险指南 》
Journal Watch推荐及评论>>Lipid-Modifying Therapy: A New Paradigm
2.《 2013 AHA/ACC 管理生活方式降低心血管风险指南 》
指南的Journal Watch推荐及评论>>2013 AHA/ACC Guidelines for a Heart-Healthy Lifestyle
3. 《2013 AHA/ACC/TOS 成人超重与肥胖管理指南》
指南的Journal Watch推荐及评论>>Guidelines for Assessment of Cardiovascular Risk
部分内容仅可在
临床指南app 查看下载
收藏
分享
COMMENT
These guidelines introduce new equations for assessing the 10-year (and also lifetime) risk for a first cardiovascular event. Calculators are available in downloadable form online and are relatively easy to use. Links to the equations are included in treatment algorithms contained in concomitantly released guidelines for management of cholesterol for primary prevention (NEJM JW Gen Med Nov 12 2013.